Defining the miRnome of Saphenous Vein Smooth Muscle Cells from Patients with Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) patients suffer premature development of cardiovascular disease and commonly require cardiac revascularization using the autologous saphenous vein (SV). Smooth muscle cells (SMCs) are the principal cell type within the vascular wall and are dysfunctional in T2DM SV-SMCs, yet the mechanisms underpinning this are incompletely understood. The purpose of this study was to interrogate differential microRNA (miRNA) expression in SV-SMCs to enhance our understanding of T2DM SV-SMC phenotypic change. miRNA expression in primary human SV-SMCs from T2DM and non-diabetic (ND) donors was determined using an array (n = 6 each of ND and T2DM SV-SMCs). Differentially expressed miRNAs were ranked, and functional annotation of the 30 most differentially expressed miRNAs using DAVID and KEGG analysis revealed pathways related to SMC phenotype, including proliferation, migration, cytokine production and cell signaling. After selecting miRNAs known to be involved in SMC phenotypic regulation, miR-17, miR-29b-2, miR-31, miR-130b and miR-491 were further validated using qRT-PCR (n = 5 each of ND and T2DM SV-SMC), with miR-29b-2 subsequently being removed from further investigation. Potential mRNA targets were identified using mirDIP. Predicted target analysis highlighted likely dysregulation in transcription, epigenetic regulation, cell survival, intracellular signaling and cytoskeletal regulation, all of which are known to be dysfunctional in T2DM SV-SMCs. In conclusion, this paper identified four miRNAs that are dysregulated in T2DM SV-SMCs and are implicated in functional changes in the behavior of these cells. This provides a step forward in our understanding of the molecular and epigenetic regulation of vascular dysfunction in T2DM.

[1]  Jiliang Hu,et al.  microRNA-130b May Induce Cerebral Vasospasm after Subarachnoid Hemorrhage via Modulating Kruppel-like Factor 4 , 2023, Molecular and cellular biology.

[2]  H. Jo,et al.  Conserved miR-370-3p/BMP-7 axis regulates the phenotypic change of human vascular smooth muscle cells , 2023, Scientific Reports.

[3]  Qiang Sun,et al.  MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcoma , 2023, PloS one.

[4]  Yuan Yan,et al.  Angiotensin II-induced miR-31-5p upregulation promotes vascular smooth muscle cell proliferation and migration. , 2022, Experimental cell research.

[5]  Hui Ding,et al.  Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells , 2022, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[6]  Jie Wang,et al.  Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis , 2022, Cell death discovery.

[7]  K. Riches-Suman,et al.  Identifying and targeting the molecular signature of smooth muscle cells undergoing early vascular ageing. , 2022, Biochimica et biophysica acta. Molecular basis of disease.

[8]  G. Iacobucci,et al.  One in 10 UK adults could have diabetes by 2030, warns charity , 2021, BMJ.

[9]  Hui Zhang,et al.  A microRNA-17-5p/homeobox B13 axis participates in the phenotypic modulation of vascular smooth muscle cells , 2021, Molecular medicine reports.

[10]  R. Touyz,et al.  MICRORNA PROFILE IN HUMAN VASCULAR SMOOTH MUSCLE CELLS FROM HYPERTENSIVE SUBJECTS: FOCUS ON OXIDATIVE AND ENDOPLASMIC RETICULUM STRESS , 2021 .

[11]  Hongming Ji,et al.  MicroRNA-29b inhibits human vascular smooth muscle cell proliferation via targeting the TGF-β/Smad3 signaling pathway , 2021, Experimental and therapeutic medicine.

[12]  K. Riches-Suman.  Diverse roles of microRNA-145 in regulating smooth muscle (dys)function in health and disease. , 2021, Biochemical Society transactions.

[13]  T. Palmer,et al.  Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylation. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  Haojie Wang,et al.  p53-Dependent LincRNA-p21 Protects Against Proliferation and Anti-apoptosis of Vascular Smooth Muscle Cells in Atherosclerosis by Upregulating SIRT7 via MicroRNA-17-5p , 2020, Journal of Cardiovascular Translational Research.

[15]  Xiehua Xue,et al.  Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation , 2020, Evidence-based complementary and alternative medicine : eCAM.

[16]  N. Turner,et al.  Role of MicroRNA-145 in DNA Damage Signalling and Senescence in Vascular Smooth Muscle Cells of Type 2 Diabetic Patients , 2020, bioRxiv.

[17]  Wenyan Li,et al.  MiR-17 knockdown promotes vascular smooth muscle cell phenotypic modulation through upregulated interferon regulator factor 9 expression. , 2020, American journal of hypertension.

[18]  Jun Ren,et al.  Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype. , 2020, European heart journal.

[19]  Manhua Chen,et al.  microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9 , 2020, Open medicine.

[20]  R. Govender,et al.  Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends , 2019, Journal of epidemiology and global health.

[21]  Ki-Bong Kim,et al.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery , 2019, Nature Reviews Cardiology.

[22]  Qinyu Ge,et al.  MicroRNA Detection Specificity: Recent Advances and Future Perspective. , 2019, Analytical chemistry.

[23]  M. Bendeck,et al.  Role of smooth muscle cells in coronary artery bypass grafting failure. , 2018, Cardiovascular research.

[24]  Shenming Wang,et al.  MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin-2 in arteriosclerosis obliterans of the lower extremitie , 2017, Experimental and therapeutic medicine.

[25]  Lin Zhao,et al.  Proliferation of vascular smooth muscle cells under inflammation is regulated by NF-κB p65/microRNA-17/RB pathway activation , 2017, International journal of molecular medicine.

[26]  Matthias Zytnicki,et al.  mmquant: how to count multi-mapping reads? , 2017, BMC Bioinformatics.

[27]  Zhongxue Wu,et al.  MiR-29b Downregulation Induces Phenotypic Modulation of Vascular Smooth Muscle Cells: Implication for Intracranial Aneurysm Formation and Progression to Rupture , 2017, Cellular Physiology and Biochemistry.

[28]  Yuan Xia,et al.  MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[29]  Carlo M. Croce,et al.  Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature , 2015, PLoS genetics.

[30]  N. Turner,et al.  Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function , 2014, Journal of molecular and cellular cardiology.

[31]  N. Turner,et al.  Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity. , 2014, Cardiovascular revascularization medicine : including molecular interventions.

[32]  J. Tao,et al.  MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. , 2013, Experimental cell research.

[33]  F. Middleton,et al.  Thrombospondin-1 differentially regulates microRNAs in vascular smooth muscle cells , 2012, Molecular and Cellular Biochemistry.

[34]  Chunxiang Zhang,et al.  MicroRNA-31 Regulated by the Extracellular Regulated Kinase Is Involved in Vascular Smooth Muscle Cell Growth via Large Tumor Suppressor Homolog 2* , 2011, The Journal of Biological Chemistry.

[35]  N. Turner,et al.  Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. , 2009, American journal of physiology. Cell physiology.

[36]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[37]  Ana Lúcia Leitão,et al.  A guide for miRNA target prediction and analysis using web-based applications. , 2014, Methods in molecular biology.

[38]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[39]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.